» Articles » PMID: 23863950

Patients Hospitalized with Laboratory-confirmed Influenza During the 2010-2011 Influenza Season: Exploring Disease Severity by Virus Type and Subtype

Abstract

Background:  The 2010-2011 influenza season was dominated by influenza A(H3N2) virus, but influenza A(H1N1) pdm09 (pH1N1) and B viruses cocirculated. This provided an opportunity to explore within-season predictors of severity among hospitalized patients, avoiding biases associated with season-to-season differences in strain virulence, population immunity, and healthcare seeking.

Methods:  Population-based, laboratory-confirmed influenza hospitalization surveillance data were used to examine the association between virus type/subtype and outcomes in children and adults. Multivariable analysis explored virus type/subtype, prompt antiviral treatment, medical conditions, and age as predictors for severity (intensive care unit admission or death).

Results:  In children, pH1N1 (adjusted odds ratio [aOR], 2.19; 95% confidence interval [CI], 1.11-4.3), chronic metabolic disease (aOR, 5.23; 95% CI, 1.74-15.69), and neuromuscular disorder (aOR, 4.84; 95% CI, 2.02-11.58) were independently associated with severity. In adults, independent predictors were pH1N1 (aOR, 2.21; 95% CI, 1.66-2.94), chronic lung disease (aOR, 1.46, 95% CI, 1.12-1.89), and neuromuscular disorder (aOR, 1.68; 95% CI, 1.11-2.52).Antiviral treatment reduced the odds of severity among adults (aOR, 0.47; 95% CI, .33-.68).

Conclusions:  During the 2010-2011 season, pH1N1 caused more severe disease than H3N2 or B in hospitalized patients. Underlying medical conditions increased severity despite virus strain. Antiviral treatment reduced severity among adults. Our findings underscore the importance of influenza prevention.

Citing Articles

Epidemiological investigation of lower respiratory tract infections during influenza A (H1N1) pdm09 virus pandemic based on targeted next-generation sequencing.

Li X, Liu Y, Li M, Bian J, Song D, Liu C Front Cell Infect Microbiol. 2024; 13:1303456.

PMID: 38162581 PMC: 10755937. DOI: 10.3389/fcimb.2023.1303456.


Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010-19: a repeated cross-sectional study.

Sumner K, Masalovich S, OHalloran A, Holstein R, Reingold A, Kirley P Lancet Microbe. 2023; 4(11):e903-e912.

PMID: 37769676 PMC: 10872935. DOI: 10.1016/S2666-5247(23)00187-8.


Predictors of Severity of Influenza-Related Hospitalizations: Results From the Global Influenza Hospital Surveillance Network (GIHSN).

Cohen L, Hansen C, Andrew M, McNeil S, Vanhems P, Kyncl J J Infect Dis. 2023; 229(4):999-1009.

PMID: 37527470 PMC: 11011157. DOI: 10.1093/infdis/jiad303.


Understanding the Global Burden of Influenza in Adults Aged 18-64 years: A Systematic Literature Review from 2012 to 2022.

Maleki F, Welch V, Lopez S, Cane A, Langer J, Enstone A Adv Ther. 2023; 40(10):4166-4188.

PMID: 37470942 PMC: 10499696. DOI: 10.1007/s12325-023-02610-1.


Outcomes after surgery in patients with and without recent influenza: a nationwide population-based study.

Lam F, Liao C, Chen T, Huang Y, Lee Y, Chiou H Front Med (Lausanne). 2023; 10:1117885.

PMID: 37358993 PMC: 10288488. DOI: 10.3389/fmed.2023.1117885.